Inoue S - Search Results

1

Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.

Fujimura T, Takahashi S, Urano T, Xiaoqiang L, Ogushi T, Muramatsu M, Ouchi Y, Kitamura T, Homma Y, Inoue S. Fujimura T, et al. Among authors: inoue s. Int J Urol. 2009 Mar;16(3):329-32. doi: 10.1111/j.1442-2042.2008.02233.x. Epub 2009 Jan 20. Int J Urol. 2009. PMID: 19207611

2

Interaction of phytoestrogens with estrogen receptors alpha and beta (II).

Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Morito K, et al. Among authors: inoue s. Biol Pharm Bull. 2002 Jan;25(1):48-52. doi: 10.1248/bpb.25.48. Biol Pharm Bull. 2002. PMID: 11824555 Free article.

3

[Estrogen receptor gene polymorphism].

Hoshino S, Inoue S, Ouchi Y. Hoshino S, et al. Among authors: inoue s. Nihon Rinsho. 2002 Mar;60 Suppl 3:111-9. Nihon Rinsho. 2002. PMID: 11979896 Review. Japanese. No abstract available.

4

Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.

Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, Ouchi Y, Inoue S. Urano T, et al. Among authors: inoue s. Nature. 2002 Jun 20;417(6891):871-5. doi: 10.1038/nature00826. Nature. 2002. PMID: 12075357

5

Augmentation of immune cell activity against tumor cells by Rauwolfia radix.

Jin GB, Hong T, Inoue S, Urano T, Cho S, Otsu K, Kitahara M, Ouchi Y, Cyong JC. Jin GB, et al. Among authors: inoue s. J Ethnopharmacol. 2002 Aug;81(3):365-72. doi: 10.1016/s0378-8741(02)00123-x. J Ethnopharmacol. 2002. PMID: 12127238

6

The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type.

Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, Inoue S, Muramatsu M, Momoeda M, Taketani Y. Kurosawa T, et al. Among authors: inoue s. Endocr J. 2002 Aug;49(4):465-71. doi: 10.1507/endocrj.49.465. Endocr J. 2002. PMID: 12402979 Free article.

7

Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts.

Fujita M, Urano T, Horie K, Ikeda K, Tsukui T, Fukuoka H, Tsutsumi O, Ouchi Y, Inoue S. Fujita M, et al. Among authors: inoue s. Biochem Biophys Res Commun. 2002 Nov 29;299(2):222-8. doi: 10.1016/s0006-291x(02)02640-2. Biochem Biophys Res Commun. 2002. PMID: 12437973

8

Induction of anti-metallothionein antibody and mercury treatment decreases bone mineral density in mice.

Jin GB, Inoue S, Urano T, Cho S, Ouchi Y, Cyong JC. Jin GB, et al. Among authors: inoue s. Toxicol Appl Pharmacol. 2002 Dec 1;185(2):98-110. doi: 10.1006/taap.2002.9531. Toxicol Appl Pharmacol. 2002. PMID: 12490134

9

Efp as a new molecular target for breast cancer therapy.

Horie K, Urano T, Inoue S. Horie K, et al. Among authors: inoue s. Anticancer Drugs. 2003 Jan;14(1):1-2. doi: 10.1097/00001813-200301000-00001. Anticancer Drugs. 2003. PMID: 12544252 Review. No abstract available.

10

Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.

Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, Koji T. Tsurusaki T, et al. Among authors: inoue s. J Clin Endocrinol Metab. 2003 Mar;88(3):1333-40. doi: 10.1210/jc.2002-021015. J Clin Endocrinol Metab. 2003. PMID: 12629127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,939 results

Search Page

Filters